A Phase II study of adjuvant therapy with anti-B4-blocked ricin after autologous bone marrow transplantation for patients with relapsed B-cell non-Hodgkin's lymphoma.

Source:http://linkedlifedata.com/resource/pubmed/id/10499609

Download in:

View as

General Info

PMID
10499609